Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue
- PMID: 17266505
- DOI: 10.2174/187152007779314017
Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue
Erratum in
-
Corrigendum to: Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue.Anticancer Agents Med Chem. 2023;23(11):1350. doi: 10.2174/187152062311230607155929. Anticancer Agents Med Chem. 2023. PMID: 37306081
Abstract
Cisplatin, carboplatin and oxaliplatin are anticancer drugs, which are efficiently used in the clinics all over the world. Besides a remarkable therapeutic efficacy in a series of solid tumors and outstanding activity of cisplatin against testicular germ-cell cancer, the platinum-based therapy is in part accompanied by a set of severe toxic side-effects. The design of platinum complexes being equipped with an exclusive selectivity for the tumoral tissue and exhibiting a lack of systemic toxicity ('magic bullets') is the great hope in the fight against cancer and also a motor within the expanding field of bioinorganic chemistry. In this review article, two promising strategies, namely accumulation and activation of tumor inhibiting platinum complexes specifically at the tumor site is presented, demonstrating a stepwise approach towards the 'magic bullet' concept propagated by Paul Ehrlich.
Similar articles
-
Recent Developments in the Field of Anticancer Platinum Complexes.Recent Pat Anticancer Drug Discov. 2006 Jun;1(2):285-95. doi: 10.2174/157489206777442287. Recent Pat Anticancer Drug Discov. 2006. PMID: 18221042 Review.
-
Toxicity of platinum compounds.Expert Opin Pharmacother. 2003 Jun;4(6):889-901. doi: 10.1517/14656566.4.6.889. Expert Opin Pharmacother. 2003. PMID: 12783586 Review.
-
Photoactivatable platinum complexes.Anticancer Agents Med Chem. 2007 Jan;7(1):75-93. doi: 10.2174/187152007779314053. Anticancer Agents Med Chem. 2007. PMID: 17266506 Review.
-
The role of sulfur in platinum anticancer chemotherapy.Anticancer Agents Med Chem. 2007 Jan;7(1):19-34. doi: 10.2174/187152007779314062. Anticancer Agents Med Chem. 2007. PMID: 17266503 Review.
-
New platinum antitumor complexes.Crit Rev Oncol Hematol. 1993 Dec;15(3):191-219. doi: 10.1016/1040-8428(93)90042-3. Crit Rev Oncol Hematol. 1993. PMID: 8142057 Review.
Cited by
-
Peptide targeting of platinum anti-cancer drugs.Bioconjug Chem. 2009 Oct 21;20(10):1869-78. doi: 10.1021/bc900065r. Epub 2009 Sep 23. Bioconjug Chem. 2009. PMID: 19775102 Free PMC article.
-
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity.Pharmaceuticals (Basel). 2019 Sep 26;12(4):146. doi: 10.3390/ph12040146. Pharmaceuticals (Basel). 2019. PMID: 31561546 Free PMC article. Review.
-
Clinical developments of antitumor polymer therapeutics.RSC Adv. 2019 Aug 8;9(43):24699-24721. doi: 10.1039/c9ra04358f. eCollection 2019 Aug 8. RSC Adv. 2019. PMID: 35528643 Free PMC article. Review.
-
Synthesis, Characterization, Crystal Structure, DNA and HSA Interactions, and Anticancer Activity of a Mononuclear Cu(II) Complex with a Schiff Base Ligand Containing a Thiadiazoline Moiety.ACS Omega. 2022 Jan 10;7(3):2881-2896. doi: 10.1021/acsomega.1c05750. eCollection 2022 Jan 25. ACS Omega. 2022. PMID: 35097283 Free PMC article.
-
1,3-diaryl-2-propenones and 2-benzylidene-1,3-indandiones: a quest for compounds displaying greater toxicity to neoplasms than normal cells.Arch Pharm (Weinheim). 2010 Sep;343(9):535-41. doi: 10.1002/ardp.200900308. Arch Pharm (Weinheim). 2010. PMID: 20806272 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources